Sarah Chapin Columbia - McDermott Will & Emery


Sarah Chapin Columbia is a Fellow in the American College of Trial Lawyers. Over the last dozen years, she has led 17 patent infringement, trade secrets and invalidity trials (11 jury trials, six bench trials) across several jurisdictions, including the federal courts in Massachusetts, Florida, Delaware, Colorado, California and Texas.

Show More


  • Lead counsel for Alnylam in ongoing patent infringement litigation involving the cationic lipids essential to the delivery of the COVID-19 vaccines (Alnylam v. Pfizer/BionTech (D. Delaware); Alnylam v. Moderna (D. Delaware))
  • Lead counsel for Next Caller in simultaneous patent infringement litigation and trade secrets, tortious interference and breach of contract litigation related to authentication services. Successfully secured a unanimous jury verdict in favor of Next Caller in both matters (TrustID Inc. v. Next Caller Inc., (D. Delaware), TRUSTID, Inc. v. Next Caller Inc., (D. Colorado))
  • Lead counsel for Amgen in a patent infringement action and jury trials involving breakthrough biologic therapy for the treatment of high LDL cholesterol (Amgen v. Sanofi, et al., (D. Delaware))

Show More


  • Euromoney,  Americas Women in Business Law Awards, Patent Lawyer of the Year, 2023
  • LMG Life Sciences – Leading Life Sciences Lawyer, 2021 to 2022
  • Managing Intellectual Property, Massachusetts Litigator of the Year, 2022; Top 250 Women in IP, 2023

Show More


  • The Sedona Conference®, Working Group on Patent Damages and Remedies


Harvard Law School, JD, magna cum laude, 1987
John F. Kennedy School of Government – Harvard University, MPP, 1987
Wesleyan University, BA, Economics 1982


Show More